ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of March

March 29, 2013

NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also

February 16, 1996

ACO Leaders Meet With Key White House, Hill Aides

March 29, 1985

Dial Access Offers Caner Consultation Services

February 21, 1975

Colorectal Cancer Screening Practices Need Improvement, CDC Practice Study Finds

April 30, 2010

Senate Confirms FDA Commissioner Von Eschenbach.

December 8, 2006